IP Library › Assignment 059185/0504
Patent Assignment
Reel/Frame 059185/0504

Assignment of Assignor's Interest

Recorded: 2022-03-07 Pages: 5
Assignor
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property (1)
Heteroaryl Plasma Kallikrein Inhibitors
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058615/0594 →
Assignment of Assignor's Interest Jan 11, 2022
From: PAPAIOANNOU, NIKOLAOS; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058615/0518 →
Assignment of Assignor's Interest Jan 11, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 058615/0568 →
Assignment of Assignor's Interest Jan 11, 2022
From: CHARLES RIVER LABORATORIES, INC.; CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058615/0610 →
Assignment of Assignor's Interest Jan 11, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058615/0986 →
Assignment of Assignor's Interest Feb 22, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 059065/0887 →
Assignment of Assignor's Interest Aug 18, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060842/0547 →